IHS Chemical Week

People & Business :: Earnings/Finance

Arkema reports lower Ebitda in fourth quarter and full year, outlines investments

10:24 AM MST | March 4, 2014 | Natasha Alperowicz in Paris

Arkema today reported fourth-quarter and full-year 2013 results and said it is confident to grow Ebitda in 2014.  Adjusted net income from continuing operations in the fourth quarter was up 4.5% to €46 million ($63.3 million) on sales down 2.5% to €1.41 billion. Ebitda was down 5.3% to €162 million and fourth-quarter Ebitda margin was 11.5% compared with 11.8% in the year-earlier period.   The company warned in January that it will not reach its Ebitda projections of €920 million in 2013. It closed 2013 with Ebitda 9.4% down at...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa